Close Menu

In PLoS ONE this week, University of Washington, Seattle, researchers report their identification of novel prognostic molecular features in acute myeloid leukemia, derived from their cross-study analyses of 25 gene expression profiling studies. One third of the 4,918 reported genes were replicated in more than one study, but only 9.6 percent of those repeated were associated with AML prognostics, the authors report.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.